Abstract
Contemporary global real-world data on the management of type 2 diabetes are scarce. The global DISCOVER study program aims to describe the disease management patterns and a broad range of associated outcomes in patients with type 2 diabetes initiating a second-line glucose-lowering therapy in routine clinical practice. The DISCOVER program comprises two longitudinal observational studies involving more than 15,000 patients in 38 countries across six continents. Study sites have been selected to be representative of type 2 diabetes management in each country. Data will be collected at baseline (initiation of second-line therapy), at 6months, and yearly during a 3-year follow-up period. The DISCOVER program will record patient, healthcare provider, and healthcare system characteristics, treatment patterns, and factors influencing changes in therapy. In addition, disease control (e.g. achievement of glycated hemoglobin target), management of associated risk factors (e.g. hypercholesterolemia and hypertension), and healthcare resource utilization will be recorded. Microvascular and macrovascular complications, incidence of hypoglycemic events, and patient-reported outcomes will also be captured. The DISCOVER program will provide i...Continue Reading
Citations
Aug 5, 2017·International Journal of Molecular Sciences·Yusuke NakatsuTomoichiro Asano
Jan 19, 2018·Journal of Diabetes·Ann M CarracherKelly L Close
Jul 13, 2019·Diabetes, Obesity & Metabolism·Antonio NicolucciStuart Pocock
Jun 20, 2019·Diabetes, Obesity & Metabolism·Kamlesh KhuntiMikhail Kosiborod
Feb 1, 2020·International Journal of Clinical Practice·Jun-Sing WangWayne Huey-Herng Sheu
Jan 17, 2020·Diabetes, Obesity & Metabolism·Suping LingKamlesh Khunti
Aug 31, 2019·Diabetes, Obesity & Metabolism·Kamlesh KhuntiUNKNOWN DISCOVER investigators
Aug 28, 2020·Diabetes, Obesity & Metabolism·Krishna K PatelSuzanne V Arnold
Nov 30, 2018·Cardiovascular Diabetology·Mikhail KosiborodUNKNOWN DISCOVER investigators
Aug 28, 2020·BMJ Open Diabetes Research & Care·Zonglin HeWai-Kit Ming
Jul 19, 2020·Advances in Therapy·Javier EscaladaDirk Müller-Wieland
Jun 7, 2020·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Naoto KatakamiUNKNOWN J-DISCOVER Study Group
Dec 21, 2017·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Naoto KatakamiUNKNOWN J-DISCOVER study group
Aug 18, 2017·Diabetes, Obesity & Metabolism·Kamlesh KhuntiStuart Pocock
Feb 12, 2021·ESC Heart Failure·Suzanne V ArnoldUNKNOWN DISCOVER investigators
Apr 15, 2021·Diabetes, Obesity & Metabolism·Kamlesh KhuntiUNKNOWN DISCOVER Investigators
Apr 15, 2021·Diabetes, Obesity & Metabolism·Kamlesh KhuntiUNKNOWN DISCOVER investigators
May 5, 2021·BMJ Open Diabetes Research & Care·Brenda BongaertsWolfgang Rathmann
Jul 13, 2021·Diabetes Research and Clinical Practice·Linong JiUNKNOWN DISCOVER Investigators
Jul 3, 2021·Diabetes, Obesity & Metabolism·Fabrice BonnetKamlesh Khunti
Jul 25, 2021·Diabetes Research and Clinical Practice·Antonio NicolucciUNKNOWN DISCOVER investigators
Dec 29, 2021·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Mitsuyoshi TakaharaUNKNOWN J-DISCOVER study group